Women and Lung Cancer Research and Preventive Services Act of 2025
Latest Action
Received in the Senate. Read twice. Placed on Senate Legislative Calendar under General Orders. Calendar No. 380.
Official Summary
Women and Lung Cancer Research and Preventive Services Act of 2025 This bill requires the Department of Health and Human Services to conduct an interagency review to accelerate lung cancer research, prevention, and awareness with respect to women and underserved populations. The review must report on the status of existing research and current knowledge gaps;identify new opportunities for collaborative research to determine the causes of lung cancer and advance prevention, screening, diagnosis, and treatment; andprovide recommendations for a national lung cancer screening strategy and public education campaign.
GovScope Watchdog™
AI Government Intelligence™The Women and Lung Cancer Research and Preventive Services Act of 2025 is a bill introduced in the 119th Congress aimed at addressing lung cancer specifically in women. While the official summary and full text of the bill are not available, the title indicates a focus on enhancing research and preventive healthcare services related to lung cancer among women. The bill has passed the House and is currently under consideration in the Senate, where it has been placed on the Senate Legislative Calendar.
This bill seeks to improve lung cancer research and preventive services for women, currently awaiting further action in the Senate.
- The bill targets lung cancer research and preventive services with a focus on women.
- It has passed the House and is now pending in the Senate as of April 22, 2026.
- No detailed summary or full text is publicly available to clarify specific provisions or funding.
['Women at risk of or affected by lung cancer', "Healthcare providers specializing in lung cancer and women's health", 'Research institutions focusing on lung cancer', 'Public health agencies involved in cancer prevention and control']
['Lack of publicly available full text limits understanding of funding sources and implementation mechanisms', 'Unclear oversight and enforcement provisions due to missing detailed bill text', 'Potential challenges in coordinating research and preventive services without specified authorities or guidelines']
The bill was introduced in the House during the 119th Congress and has successfully passed that chamber. It is currently under Senate consideration, placed on the legislative calendar. The absence of a public summary or full text limits insight into the detailed legislative intent or bipartisan support levels.
Hidden impact flags detected: 2
GovScope reviewed 2 policy-risk categories. Hover for a quick definition. Click detected flags for bill-specific details.
['Potential increased funding and focus on lung cancer research may lead to advancements benefiting broader cancer research fields.', 'Enhanced preventive services for women could improve early detection rates and reduce lung cancer mortality among women.', 'Healthcare systems may need to adapt to incorporate new preventive services or research findings.']
The absence of the full bill text and official summary limits transparency and hinders comprehensive analysis. Monitoring future disclosures of the bill's provisions, funding mechanisms, and oversight structures will be important for assessing its impact and implementation. The current legislative status indicates the bill is still in process, with no final passage or enactment information available.
GovScope Intelligence Roadmap
Future bill intelligence will connect sponsors, committee referrals, related votes, campaign finance, disclosures, and stock trades into one legislative intelligence view.